C
Carlos Alvarez-Ibarra
Researcher at Complutense University of Madrid
Publications - 77
Citations - 583
Carlos Alvarez-Ibarra is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Methylene & Enantioselective synthesis. The author has an hindex of 14, co-authored 77 publications receiving 558 citations. Previous affiliations of Carlos Alvarez-Ibarra include University of Barcelona.
Papers
More filters
Journal ArticleDOI
Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
Carlos Alvarez-Ibarra,Rocío Fernández-Granda,María L. Quiroga,Angélica Carbonell,Francisco Cárdenas,Ernest Giralt +5 more
TL;DR: Three structural features seem to be essential for antitumor activities: a positive charge density at carbon C-7, a side chain at position C-2 or C-9 of the thiazoloquinoline skeleton with two basic nitrogens and a pKa value of 7.5-10 in the most basic center, and a conformational flexibility of this basic side chain.
Journal ArticleDOI
Synthesis of gamma,delta-didehydrohomoglutamates by the phosphine-catalyzed gamma-addition reaction to acetylenic esters
Journal ArticleDOI
Synthesis, Configurational Assignment and Conformational Analysis of .beta.-Hydroxy Sulfoxides, Bioisosteres of Oxisuran Metabolites, and their O-Methyl Derivatives
Journal ArticleDOI
Carboxylates as pronucleophiles in the phosphine-catalyzed γ-addition reaction
TL;DR: Carboxylates have been used as pronucleophiles in the phosphine-catalyzed γ-addition reaction to alkynes bearing electron-withdrawing groups as discussed by the authors.
Journal ArticleDOI
Diastereoselective Synthesis of alpha,alpha-Disubstituted gamma-Carboxypyroglutamates via Sm(III)-Azomethine Ylide Cycloadditions.
TL;DR: Cycloaddition of ylides 2 with alpha,beta-unsaturated esters 3 through a transition state chelation-controlled by the metal allowed for the asymmetric synthesis of gamma-carboxypyroglutamates having a quaternary alpha-carbon that are potentially useful in the synthesis of neuroprotective agents.